Press release from CNW Group
Aeterna Zentaris to Present at Upcoming Rodman & Renshaw Annual Global Investment Conference in New York
Thursday, August 29, 2013
Aeterna Zentaris to Present at Upcoming Rodman & Renshaw Annual Global Investment Conference in New York07:30 EDT Thursday, August 29, 2013
QUÉBEC CITY, Aug. 29, 2013 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the Company's President and CEO, David Dodd, will be presenting a corporate overview at the Rodman & Renshaw Annual Global Investment Conference on Monday, September 9, 2013, at 10:50 am (Eastern), in Room 7.02 of the Millennium Broadway Hotel, in New York.
A live audio webcast of this presentation will be available on Aeterna Zentaris' website at www.aezsinc.com in the Newsroom section. A replay of the webcast will also be available on the Company's website for a period of 90 days.
About Aeterna Zentaris
Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology. The Company's pipeline encompasses compounds from drug discovery to regulatory approval. For more information, visit www.aezsinc.com.
SOURCE: Aeterna Zentaris Inc.
For further information:
Ginette Beaudet Vallières
Investor Relations Coordinator
(418) 652-8525 ext. 265
Director of Communications
(418) 652-8525 ext. 406